|
Outcomes of elderly treated with pembrolizumab for metastatic melanoma comparing with younger patients. |
|
|
Travel, Accommodations, Expenses - MSD; Novartis; Roche |
|
|
No Relationships to Disclose |
|
|
Travel, Accommodations, Expenses - MSD; Roche |
|
|
Travel, Accommodations, Expenses - BMS Brazil; MSD; Roche |
|
|
|
|
|
No Relationships to Disclose |
|
|
Employment - Merck Sharp & Dohme |
Stock and Other Ownership Interests - Merck Sharp & Dohme |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |